Cargando…

SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7

The protein methyltransferase SET and MYND domain-containing protein 2 (SMYD2) is a transcriptional regulator that methylates histones and nonhistone proteins. As an oncogene, SMYD2 has been investigated in numerous types of cancer. However, its involvement in lung cancer remains elusive. The progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lei, Kou, Fan, Ji, Zhenyu, Li, Baihui, Zhang, Bailu, Guo, Yan, Yang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089105/ https://www.ncbi.nlm.nih.gov/pubmed/33935284 http://dx.doi.org/10.1038/s41419-021-03720-w

Ejemplares similares

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Baicalein Inhibits the SMYD2/RPS7 Signaling Pathway to Inhibit the Occurrence and Metastasis of Lung Cancer
por: Gu, Lin, et al.
Publicado: (2022)

Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
por: Kou, Fan, et al.
Publicado: (2022)

ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
por: Zhou, Zhenyu, et al.
Publicado: (2019)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
por: Kim, Kwangho, et al.
Publicado: (2023)

Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
por: Yoshioka, Yuichiro, et al.
Publicado: (2017)

Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy
por: Kou, Fan, et al.
Publicado: (2022)

SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis
por: Yue, Fu-Ren, et al.
Publicado: (2020)

RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial–mesenchymal transition and stem-like reprogram
por: Yan, Cihui, et al.
Publicado: (2021)

METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
por: Li, Rong, et al.
Publicado: (2022)

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer
por: Ikram, Sabeen, et al.
Publicado: (2023)

MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK‐3β/β‐catenin signalling
por: Shi, Yangfeng, et al.
Publicado: (2021)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2
por: Cao, Fuyang, et al.
Publicado: (2022)

Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
por: Lei, Yubin, et al.
Publicado: (2017)

BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells
por: Kim, Jeong Seon, et al.
Publicado: (2015)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

SMYD2 promotes cervical cancer growth by stimulating cell proliferation
por: Sun, Jun-Jie, et al.
Publicado: (2019)

The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
por: Codato, Roberta, et al.
Publicado: (2019)

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis
por: Bowley, Tetiana Y., et al.
Publicado: (2022)

Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin pathway
por: Wang, Zuoyun, et al.
Publicado: (2020)

Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury
por: Zhang, Hao, et al.
Publicado: (2022)

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021)

STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
por: Ma, Wei, et al.
Publicado: (2018)

Yeast strains with N-terminally truncated ribosomal protein S5: implications for the evolution, structure and function of the Rps5/Rps7 proteins
por: Lumsden, Thomas, et al.
Publicado: (2010)

The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish
por: Xiao, Deyong, et al.
Publicado: (2018)

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma
por: Yu, Ting-Ting, et al.
Publicado: (2018)

RPS Micro Diskette
Publicado: (2017)

Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
por: Reynoird, Nicolas, et al.
Publicado: (2016)

Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
por: Li, Linda Xiaoyan, et al.
Publicado: (2018)

SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
por: Zhang, Yanjun, et al.
Publicado: (2022)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016)

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
por: Zhang, Heyun, et al.
Publicado: (2021)

DDX17 promotes the growth and metastasis of lung adenocarcinoma
por: Liu, Xiaohui, et al.
Publicado: (2022)

Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma
por: Zheng, Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fieesl9a0lnblaqdmfonv6vg73